Modulation of inflammatory response in sepsis by proteasome inhibition

International Journal of Experimental Pathology

Volumn 87, Issue 5, 2006, Pages 369-372

  Šafránek, Roman ^a,b   Ishibashi, Nobuya ^a   Oka, Youske ^a   Ozasa, Hiroyuki ^a   Shirouzu, Kazuo ^a   Holeček, Milan ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytokine; Inflammatory response; MG 132; Proteasome inhibitor; Sepsis

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; PROTEASOME; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

EID: 33748556585     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2006.00490.x     Document Type: Article

References (12)

1. Cuschieri J., Gourlay D., Garcia I., Jelacic S. & Maier R.V. (2004) Implications of proteasome inhibition: an enhanced macrophage phenotype. Cell. Immun. 227, 140-147.
2. Di Napoli M. & Papa F. (2003) MLN-519. Millennium/PAION. Curr. Opin. Investig. Drugs 4, 333-341.
3. Glauser M.P. (2000) Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit. Care Med. 28, S4-8.
4. Haddad J.J. & Fahlman C.S. (2002) Nuclear factor-κB-independent regulation of lipopolysaccharide-mediated interleucin-6 biosynthesis. Biochem. Biophys. Res. Commun. 291, 1045-1051.
5. Hobler S.C., Williams A., Fischer D. et al. (1999) Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. Am. J. Physiol. 277, R434-R440.
6. 3VS on protein metabolism in septic rats. Int. J. Exp. Path. 85, 365-371.
7. Lucker G.D., Pica C.M., Song J., Lucker K.E. & Piwnica-Worms D. (2003) Imaging 26S proteasome activity and inhibition in living mice. Nat. Med. 9, 969-973.
8. Manley M.O., O'Riordan M.A., Levine A.D. & Latifi S.Q. (2005) Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23, 521-526.
9. Richardson P.G., Hideshima T., Mitsiades C. & Anderson K. (2004) Proteasome inhibition in hematologic malignancies. Ann. Med. 36, 304-314.
10. Riedermann N.C., Guo R.F. & Ward P.A. (2003) The enigma of sepsis. J. Clin. Invest. 112, 460-467.
11. Singleton K.D. & Wischmeyer P.E. (2003) Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur. Surg. Res. 35, 486-491.
12. Tsubuki S. Saito Y., Tomioka M., Ito H. & Kawashima S. (1996) Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J. Biochem. 119, 572-576.